Exemestane or Anastrozole in Treating Postmenopausal Women Who Have Undergone Surgery for Primary Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: anastrozole|DRUG: exemestane
Sponsor: NCIC Clinical Trials Group
Collaborators: National Cancer Institute (NCI)|North Central Cancer Treatment Group|Cancer and Leukemia Group B|Eastern Cooperative Oncology Group|SWOG Cancer Research Network|ETOP IBCSG Partners Foundation